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Background 
Nosocomial infection occurs commonly in intensive care units (ICU).   Although 
critical illness is associated with immune activation, the prevalence of 
nosocomial infections suggests concomitant immune suppression.  
This study examined the temporal occurrence of immune dysfunction across 
three immune cell types, and their relationship with the development of 
nosocomial infection. 
 
Methods 
A prospective observational cohort study was undertaken in a teaching hospital 
general ICU.  Critically ill patients were recruited and underwent serial 
examination of immune status, namely percentage regulatory T-cells (Tregs), 
monocyte deactivation (by HLA-DR expression) and neutrophil dysfunction (by 
CD88 expression).  The occurrence of nosocomial infection was determined 
using pre-defined, objective criteria.  
 
Results 
Ninety-six patients were recruited, of whom 95 had data available for analysis.   
Relative to healthy controls, percentage Tregs were elevated 6-10 days after 
admission, whilst monocyte HLA-DR and neutrophil CD88 showed broader 
depression across time points measured.  Thirty-three patients (35%) developed 
nosocomial infection, and patients developing nosocomial infection showed 
significantly greater immune dysfunction by the measures employed. Tregs and 
neutrophil dysfunction remained significantly predictive of infection in a Cox 
hazards model correcting for time effects and clinical confounders (HR 2.4 (95% 
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CI 1.1-5.4) and 6.9 (95% CI 1.6-30) respectively, p=0.001). Cumulative immune 
dysfunction resulted in a progressive risk of infection, rising from no cases in 
patients with no dysfunction to 75% of patients with dysfunction of all three cell 
types (p=0.0004). 
 
 
Conclusions  
Dysfunctions of T-cells, monocytes and neutrophils predict acquisition of 
nosocomial infection, and combine additively to stratify risk of nosocomial 
infection in the critically ill.   
 
 
Key Words: Neutrophils, monocytes, regulatory T-lymphocytes, critical illness, 
nosocomial infection 
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Many diseases that can precipitate the need for exogenous organ support and 
admission to intensive care are characterized by a profound systemic 
inflammatory response1, with associated immune cell activation 2 and immune 
system-mediated organ damage3.  However it is now increasingly apparent that 
this over-exuberant inflammation is accompanied by an equally vigorous 
counter-regulatory anti-inflammatory response 4. 
 
The anti-inflammatory response to the systemic inflammatory response 
syndrome (SIRS) manifests across a range of cellular actions and functions, 
involving both the innate and adaptive arms of the immune system 4  Defects 
have been noted in neutrophils 5-8, monocytes 9, T lymphocytes 10 as well as B 
lymphocytes and splenic dendritic cells 11,12.  
 
The recent identification of elevated levels of regulatory helper-T cells (Tregs) in 
sepsis 13 is in keeping with the supposition that much of the immunosuppression 
arises from the over-activation of counter-regulatory mechanisms.  In human 
and experimental sepsis, Tregs impair the proliferative response of lymphocytes 
14.  
 
The demands of organ support require the disruption of physical and 
physiological barriers through the placement of devices such as endo-tracheal 
tubes.  It is thought that the combination of immune vulnerability and such 
routes of microbial colonization are responsible for the high rates of nosocomial 
infection seen in critically ill patients 15.  These secondary infections typically 
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occur in 25-35% of those admitted to intensive care units (ICUs) 15, a rate that 
approaches that seen in neutropaenia 16.   These infections are associated with 
increased length of stay 17, morbidity 18 and mortality 19, and therefore are of 
considerable concern to patients and clinicians.  Although it seems plausible that 
the immune defects found in critical illness are associated with the acquisition of 
nosocomial infection, there is little published evidence for this, and what data 
there are concentrates on single types of immune cell.  Furthermore the 
temporal relationship between immune dysfunction and nosocomial infection is 
not always clear 6, limiting any inferences regarding causality.  
 
This study aimed to characterise the temporal patterns of three measures of 
immune dysfunction, sampling both the innate and adaptive arms of the immune 
system, and to derive potential new biomarkers of susceptibility to nosocomial 
infection.  The cell types and measures of dysfunction chosen were; the level of   
Tregs as a percentage of all CD4+ lymphocytes14, monocyte deactivation assayed 
by monocyte HLA-DR expression 9 and C5a-mediated neutrophil dysfunction  
assayed by surface CD88 expression 6, 8.  
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Methods 
 
Reagents 
 
Fluorescein isothiocyanate (FITC)-conjugated murine anti-human CD4, 
allophycocyanin (APC)-conjugated murine anti-human CD25, and phycoerythrin 
(PE)-conjugated murine anti-human FOXP3 antibodies were obtained from 
eBioscience (San Diego, CA, USA).  Red cell lysis buffer, fixation/permeabilization 
solution and flow staining buffer were obtained from eBioscience. Alexa Fluor™ 
647-conjugated murine anti-human CD88 antibodies were obtained from AbD 
Serotec (Abingdon, UK), and QuantiBRITE monocyte HLA-DR assay was obtained 
from Becton Dickson Biosciences (Oxford, UK). Tri-colour (TC)-conjugated 
murine anti-human CD16 and CD62L, FITC-conjugated murine anti-human 
CD11b and CD14, and PE-conjugated murine anti-human CD3 and CD64 were 
obtained from Invitrogen (Paisley, UK).  
 
 
 
Volunteers, Patients and Setting 
Healthy volunteers were recruited from University of Edinburgh staff, to act as a 
reference group for the cellular markers examined.  
 
The clinical study took place in an 18-bed teaching hospital medical-surgical ICU.  
Critically ill patients, defined as those admitted to ICU and requiring support of 
one or more organ systems (invasive ventilation; requirement for vasopressors 
and/or inotropes; or haemofiltration) and predicted to require such support for 
48 hours or more, were screened for recruitment.  Exclusion criteria were: age 
<16; pregnancy; known human immunodeficiency virus (HIV) infection; known 
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in-born errors of neutrophil metabolism; hematological malignancy; use of 
immunosuppressive drugs other than corticosteroids; and those thought 
unlikely to survive for more than 24 hours. Patients were also excluded if they 
were involved in another study that involved blood sampling, or if they had 
suspected H1N1 influenza.   Informed consent was obtained directly from 
patients where possible, otherwise informed consent was obtained from the next 
of kin.  Clinical data were collected regarding potential risk factors for 
nosocomial infection 15, these data included ‘shock’, defined by requirement for 
noradrenaline, adrenaline and/or dobutamine infusion.  EDTA anti-coagulated 
blood was collected at study enrolment (within 48 hours of ICU admission), then 
at study day 2, days 3-4 and days 6-10 unless a study end-point was achieved.  
Study end-points were - ICU-acquired infection (see Supplementary Section for 
definition); death without ICU-acquired infection; or discharge from ICU without 
ICU-acquired infection. 
 
Flow cytometry and Immune dysfunction 
Flow cytometry was conducted on whole blood/EDTA samples.  Neutrophils, 
monocytes and lymphocytes were identified by their size and granularity 
(forward and side scatter respectively) characteristics with confirmation that 
these populations were predominantly CD16hi (neutrophils), CD14hi(monocytes) 
and CD3pos (lymphocytes). 
Tregs were identified by CD4, CD25, FOXP3 positivity 20, using the 
manufacturer’s instructions for staining and permeabilisation, and expressed as 
a percentage of total CD4 (Thelper) lymphocytes.  
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The flow cytometer (FACSCalibur, BD Bioscience, Oxford, UK) was calibrated 
weekly using caliBRITEtm beads (3 colour and APC, BD Biosciences), linearity and 
sensitivity by 8 peak beads (Spherotech, Lake Forrest, IL, USA).  QuantiBRITEtm 
beads (BD Bioscience) were run for quantification of HLA-DR-PE expression (see 
supplemental section, Figure S1). 
 
Infections 
Diagnostic criteria were pre-defined for the major ICU-acquired infections, 
namely ventilator-associated pneumonia (VAP), blood stream infection (BSI), 
vascular catheter-related infection (CRI), urinary tract infection (UTI) and 
surgical site/soft tissue infections, based on those from the HELICS programme21 
(see supplemental section for details). Data on infections were recorded by the 
study nurses (JA and CM), who were blinded to the immune phenotype.  Day of 
infection was defined as the day on which positive microbial culture was 
obtained from the patient.   
 
Where infection was strongly clinically suspected but did not fulfil HELICS 
criteria (for instance when cultures were taken whilst on antibiotics and/or 
cultures were negative/equivocal), an expert panel (IFL, AWH, DGS, TSW and 
AJS), blinded to the immune phenotype, reviewed patients’ data and the 
presence or absence of infection was adjudicated. In the absence of positive 
cultures the day of infection was defined as the day of clinical deterioration.   The 
adjudication outcome could be ‘confirmed’, ‘probable’ or ‘unlikely’ infection.  
Details of diagnostic criteria and expert panel adjudication procedures are set 
out in the Supplementary Section. 
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Analysis plan 
 To allow cellular analysis to be dichotomised into ‘dysfunction’ or ‘no 
dysfunction’, the cut-off points for percentage of Tregs, monocyte HLA-DR and 
CD88 were examined in a planned interim analysis at 60 patients 8.  This analysis 
was performed by constructing receiver operator characteristic (ROC) curves 
comparing the sample most temporally related to infection (censored for two 
days prior) with samples from patients who did not develop infection, using 
Youden’s method 22 to determine the optimal cut-off.  
 
Patients were categorized by the sample taken most proximally to an end-point 
(death, infection, or discharge without infection) although in the case of those 
acquiring infection dysfunction was censored for 2 days prior to the diagnosis of 
infection in order to reduce the risk that observed dysfunction levels might 
reflect the presence of new infection.  Patients were also analyzed to determine 
whether their immune dysfunction status changed during admission. 
 
Statistical analysis 
Analysis was conducted using Prism (Graphpad Software, La Jolla, CA, USA) and 
PASW Statistics Version 18 (IBM Corp, Armonk, NY, USA).  
 
Contingency tables were analyzed by Fisher’s exact test (for 2x2) and chi-
squared (for >2x2). Continuous data that were not normally distributed were 
log-transformed to normality to permit parametric analysis, with one way or two 
way ANOVA used as appropriate. A Cox hazards model was constructed to 
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examine the effects of immune dysfunctions and other clinical variables on 
acquisition of infection over time.   Variables for inclusion in the final Cox model 
were selected by step-wise conditional entry with a threshold of P≤0.05.  P≤0.05 
was considered statistically significant.  
 
Ethical approval 
Written informed consent was obtained from the patient, or where incapacitated 
from their nearest relative.  The study was approved by the Scotland A Research 
Ethics committee (study number 09/MRE00/19).    Healthy volunteers provided 
written informed consent, and their involvement was approved by Lothian 
Research Ethics committee (study number 08/S1103/38). 
 
Data relating to C5a-mediated dysfunction in the first 60 patients described here 
have been published elsewhere in a paper delineating the mechanisms of C5a-
dependent impairment of neutrophil phagocytosis and its clinical relevance 8. 
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Results 
 
Recruitment 
Ninety-six patients were recruited. Blood samples were missing for one patient 
and so 95 entered the final analysis. 42 (44%) patients were admitted with 
sepsis, 9 of whom had acquired their infection in hospital prior to ICU admission.  
Details of sites and organisms involved are shown in Tables S1 and S2 in the 
supplemental section. 
 
Infections 
Thirty-three patients (35%) developed nosocomial infection whilst in ICU (26 
confirmed infections and 7 probable).  Details of the sites of infections are shown 
in Table 1, infecting organisms are shown in Table 2. The median length of stay 
before developing infection was 6 days (IQR 5-7 days).  In total 20 patients 
underwent adjudication panel review, 5 were ruled ‘confirmed’, 7 ‘probable’ and 
8 ‘unlikely’.   Further details of adjudications can be found in the supplemental 
section. Amongst the patients admitted with sepsis, who subsequently developed 
ICU-acquired infection, the organisms differed in every case and in all but one 
case the site of the new infection was different (the exception being a patient 
admitted with BAL PCR-positive Varicella pneumonitis who subsequently 
developed Gram negative bacterial VAP). 
 
22 (23%) of patients died during their ICU admission, 11 (50%) were judged to 
have died of a septic insult, including 5 with an admission diagnosis of sepsis and 
6 who developed secondary sepsis from an ICU-acquired infection. 
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Leucocyte counts in patients 
Patients had elevated total white cell counts on admission (mean 14.1 x109 L-1, 
95% CI 12.4-15.9 x109 L-1, normal range (NR) 4.0-12.0 x109 L-1). Neutrophil 
counts were also elevated (mean 11.8 x109 L-1, 95% CI 10.2-13.4, NR 2-7.5 x109 
L-1).  Lymphocyte counts were suppressed (mean 1.1 x109 L-1, 95% CI 0.9-1.2 
x109 L-1, NR 1.5-4 x109 L-1), whilst mean monocyte counts were within the 
normal range (mean 0.7 x109 L-1,  95% CI, 0.6-0.9 x109 L-1, 0.2-0.8 NR x109 L-1).  
When stratified by patients subsequently developing infection or not, total white 
cell count was significantly more elevated in patients developing infection, with 
this effect persisting when samples were censored for two days prior to 
infection. The increased white cell count was mostly due to neutrophilia (see 
Figure S2A and B in supplemental section).  By contrast lymphocyte and 
monocyte numbers didn’t differ between the groups, although both showed 
significant rises over time (Figure S2C and D). 
 
Regulatory T-cells 
The percentage of Tregs at the various time points after study entry, compared 
to healthy donors Treg levels, were higher than those seen in healthy donors, 
although the difference only became significant between days 6-10 (Figure S3A 
supplemental section).  When divided into patients developing nosocomial 
infection in the ICU and those not, Tregs were significantly higher amongst 
patients developing infection (p=0.012) (Figure 1A). 
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Monocyte deactivation 
The expression of monocyte surface HLA-DR at various time points after study 
entry, in contrast to the Tregs, were suppressed relative to healthy volunteers at 
every time point from study enrolment onwards (Figure S3B supplemental 
section).  Patients developing nosocomial infections had significantly lower 
levels of monocyte HLA-DR than those who did not (p=0.018) (Figure 1B). 
 
Complement mediated neutrophil dysfunction 
Significantly depressed levels of neutrophil CD88 were found in patients, relative 
to healthy donors, at all time points examined except on the first sample 
(Supplemental Figure S3C).  Again patients who subsequently developed 
nosocomial infection displayed lower levels of CD88, implying greater levels of 
C5a exposure (p=0.001) (Figure 1C).  In keeping with previous work 6,8, no 
association was found between nosocomial infection and other markers of 
neutrophil activation (CD11b, CD64 and L-selectin, data not shown), suggesting 
that the effect seen is not specific to CD88/C5a exposure and not reflective of 
generic activation. 
 
Examining the cut-off for dysfunction by relationship to infection 
At the interim analysis 8, the optimal cut-points were examined using ROC curves 
and Youden’s index 22; this revealed an optimal cut-point of 9.8% for Tregs, 
10,000 molecules per cell for HLA-DR and a geometric mean fluorescence of 246 
for CD88.  
Thirty-seven patients had Treg levels >9.8% prior to achieving a study endpoint 
(i.e. ICU-acquired infection, death without infection or discharge without 
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infection), the majority of whom (26, 70%) had normal levels on study 
admission.  The remaining 58 patients had levels below 9.8%, although in 8 
(14%) of them levels had started >9.8% and fallen prior to study endpoint.  As 
noted above, in patients acquiring infection in ICU, data were censored for two 
days prior to infection for purposes of classifying Treg status.  This changeability 
in Treg status led us to analyse this as a time-dependent variable in the Cox 
hazard analysis (see below).  Of note many patients showed evidence of 
increased CD25 positive lymphocytes, a known marker of lymphocyte activation 
23, reinforcing the need for FOXP3 staining in addition to cell surface markers of 
regulatory status 20. 
 
62 patients had monocyte dysfunction whilst 69 had neutrophil dysfunction. In 
contrast to the Tregs, patients were far less likely to change from ‘dysfunction’ to 
‘no dysfunction’ (or vice versa) with respect to monocyte HLA-DR and neutrophil 
CD88 expression. 75% of patients remained in the same monocyte group as their 
admission sample, whilst 13% progressed from ‘no dysfunction’ to ‘dysfunction’ 
and 14% went in the opposite direction.  Of the minority who changed groups, all 
but 2 were in their eventual group by day 3 post-admission. Regarding 
neutrophil groups 84% of patients remained in the same group as their 
admission sample, whilst 13% progressed from ‘no dysfunction’ to ‘dysfunction’ 
and 3% went in the opposite direction.  Of the minority who changed groups, all 
but 3 were in their eventual group by day 3 post-admission. 
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Effect of dysfunction on acquisition of infection 
Those patients whose Tregs were above 9.8% had an increased risk of acquiring 
nosocomial infection, with a relative risk increase of 2.4 (95%CI 1.3-4.2, p=0.002 
by Fisher’s exact test).   Monocyte deactivation, at the cut-off of 10, 000, was 
associated with a significantly increased risk of infection; relative risk of 3 
(95%CI 1.3-6.9, p=0.0035 by Fisher’s exact test).  C5a-mediated neutrophil 
dysfunction was also associated with an increased relative risk of 4.7, (95% CI 
1.2-18.3, P=0.007 by Fisher’s exact test).  In sensitivity analyses all three 
measures retained their significant values when ‘probable’ infections were 
excluded, as well as when urinary tract infections were excluded (data not 
shown). 
 
Using these same cut-offs to examine other outcomes (all cause mortality and 
death from sepsis), none of the measures showed significant association with all-
cause death (Tregs p=0.79, monocyte deactivation p=0.42 and neutrophil 
dysfunction p=0.2, all analyses by Fisher’s exact test).  When examining death 
from sepsis, only neutrophil dysfunction was significantly associated (p=0.03 by 
Fisher’s exact test, Tregs p=0.09 and monocyte deactivation p=0.32).     
 
Evaluation of the impact of other clinical variables on acquisition of infection 
As an exploratory analysis data concerning demographic and clinical factors 
previously associated with nosocomial infection 15 were entered into a Cox 
hazards model, in a conditional stepwise approach using a threshold of p≤0.05  
(Table 3). Elevated Tregs were treated as a time-dependent co-variate as this 
measure showed considerable variability over time.  In this model both Tregs 
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and neutrophil dysfunction retained their significant association (Table 4), 
however monocyte deactivation became non-significant (p=0.29) and was 
excluded from the final model.   The only clinical predictor found to be significant 
was blood transfusion, which was associated with a lower risk of nosocomial 
infection.  The overall model and hazard ratio estimates for the predictor 
variables are shown in table 4. 
 
An alternative method of variable selection for the Cox model, using univariate 
regression resulted in Tregs and neutrophil dysfunction remaining significant at 
p=0.05 but again monocyte deactivation lost significance (Tables S3 and 4, 
supplemental section). 
 
Finally the effect of cumulative occurrence of immune dysfunction was analyzed. 
Patients were analyzed by whether they had 0,1,2 or 3 dysfunctions (Table 5). 
This demonstrated an incremental risk of nosocomial infection with 
accumulating immune dysfunctions, ranging from none in those patients without 
immune dysfunctions to 75% of those who had all three (P=0.0004 by Chi2 test 
for trend).   Cumulative immune dysfunction did not predict all cause mortality 
(p=0.25 by Chi2 test for trend), but was highly significant when looking at deaths 
from sepsis (p=0.0072 Chi2 test for trend). 
 
Effect of infection on dysfunction 
To examine whether the development of ICU-acquired infection altered the 
measures of dysfunction, samples from time points before and after ICU-
acquired infection were examined (Figure 2A-C) and demonstrated no 
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significant change across the time intervals examined.  Analysis of the measures 
of dysfunction in the first samples taken from patients with and without 
infection on admission revealed no significant difference between these two 
groups (% Tregs p=0.41 HLA-DR p=0.49 CD88 p=0.73, by t-test on log 
transformed data). 
 
 
Discussion 
 
This study demonstrates the temporal course of three measures of immune 
dysfunction amongst critically ill patients, illustrating that immune dysfunction 
is not an ‘all or nothing’ response and can affect different cell types at different 
times.  Although the magnitude of immune dysfunction appears to worsen as the 
critical illness progresses, in many cases patients demonstrate dysfunction early 
on (i.e. within 48 hours of ICU admission).  Interestingly this study does not 
support the recent suggestion that immune dysfunction is restricted to patients 
with sepsis 12, as we found evidence of dysfunction amongst patients with both 
sterile and infective causes of critical illness. 
 
This study demonstrates, for the first time, an association between elevated 
Tregs and the acquisition of nosocomial infection.  The association with infection 
is also extended to diminished neutrophil CD88 expression, and both compare 
well to the more established marker, reduced monocyte HLA-DR 9.  
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This study involved assessment of several distinct mechanisms of immune 
dysfunction, and allowed for dynamic changes in immune cell function rather 
than relying on a single time point. Immunophenotyping in critical illness is a 
relatively new field, and determining what constitutes ‘immune dysfunction’ and 
how this could be determined by quantifying cell surface markers remains 
uncertain.  This study, whilst exploratory in nature, has derived two potential 
new markers for susceptibility to nosocomial infection alongside a more 
established marker.    
 
It is interesting that the cut-offs determined by examining patients with and 
without nosocomial infection were close to those suggested by more mechanistic 
work.  A cut-off of 10% of CD4 cells was suggested as an indicator of 
inappropriately elevated Tregs in a recent study 14, very close to our value of 
9.8%.  Similarly the cut-off for CD88 of 246 arbitrary fluorescence units is close 
to the value of 250 which in our hands corresponded to 50% of neutrophils 
capable of efficient phagocytosis of zymosan in patients 8. The cut off described 
here is also close to the value we observed when healthy volunteer neutrophils 
were exposed to 10nM C5a 8 which is well within the concentration range seen in 
severe sepsis 24.  Our cut-off for HLA-DR was higher than that described in 
previous studies 9 although the previous measure was looking at risk of death 
rather than development of nosocomial infection. 
 
 The infections had to meet rigorous, reproducible criteria and any cases not 
meeting these criteria underwent review by experts blinded to the immune cell 
data. Urinary tract infections (UTI) can be difficult to discern in critically ill 
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patients, given the risk of bladder colonisation with catheterisation 25. However 
those patients acquiring UTI had no clinical or microbiological evidence of 
infection from other sites and all exceeded the rigorous microbiological criteria 
set before the study (i.e. all UTIs were single organisms grown at high 
concentrations of >106 CFU ml-1).  Encouragingly, excluding UTIs or infections 
only judged ‘probable’ did not significantly reduce the predictive ability of our 
immune markers.  These findings will, however,  require further confirmation in 
an independent validation data set. 
 
As with any observational study we cannot be certain that the observed 
associations are causative, however we took steps to minimize the risk of picking 
up epiphenomenal changes associated with infection.  Indeed, analysis of the 
measures before and after the acquisition of infection did not support a simple, 
epiphenomenal relationship. Furthermore, it is biologically plausible that 
immune dysfunction is causally linked to the acquisition of nosocomial infection.  
Although we cannot rule out the effect of residual confounding from unmeasured 
variables, we have accounted for many of the risk factors previously mooted for 
nosocomial infection 15. 
 
Several studies have demonstrated elevated levels of Tregs in patients with 
sepsis 13, 14, and recent animal and in vitro work has shown Tregs mediating 
impaired T-cell proliferative responses in this disease 14.  The current study 
extends the findings of elevated Tregs to critically ill patients without sepsis, 
suggesting that their elevation is part of a stereotyped response to systemic 
inflammation rather than a specific response to severe infection.   Although the 
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association between elevated Tregs and adverse outcomes is consistent with 
some previous work 14, this finding is by no means universal with other studies 
showing no effect 26, or even protective effects in animal models27. It is also 
interesting to note the generally increased expression of CD25 noted on CD4 
cells from critically ill patients, reflecting the nature of CD25 as a marker of 
lymphocyte activation 23 and emphasising the need for additional measures such 
as FOXP3 for identifying Tregs in this patient population.   The field of regulatory 
T-cell identification is developing rapidly, and additional measures beyond those 
used in this study may further improve the predictive ability and add new 
information regarding expression of sub-sets of regulatory T-cells in critical 
illness 28.  Indeed use of CD127 negativity 14 as a marker would eliminate a step 
of the current process and produce a more rapidly available result, however 
these developments would require validation in a further study. 
 
Although the finding of monocyte deactivation, and low HLA-DR expression, 
predicting nosocomial infection is not a new one 29, 30 the finding is not 
universally consistent 31.   The role of excessive complement activation in the 
pathogenesis of sepsis and non-septic critical illness is increasingly recognised 
32,33.  Animal models of sepsis and trauma, and patient studies, have 
demonstrated C5a-mediated neutrophil dysfunction 6-8, 34.  
 
To our knowledge this is the first study to examine several different cellular 
markers of immune dysfunction simultaneously at multiple time points, and to 
demonstrate a cumulative effect when it comes to predicting nosocomial 
infection.  It remains a distinct possibility that the effects are not simply additive, 
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but may indeed be synergistic. There is evidence of neutrophil subsets 
suppressing lymphocyte functions35 and regulatory T-cells inhibiting neutrophil 
functions36.  The current study was not designed to answer such questions, 
however investigation of potential interactions is the subject of ongoing studies. 
 
It is interesting to speculate why our study did not show significant effects of 
many of the demographic and clinical factors that have been previously linked to 
nosocomial infection 15. It is important to note that although there are a variety 
of acknowledged risk factors - including severity of illness, intubation, total 
parenteral nutrition and tracheostomy 37-43  – there is relatively low concordance 
between studies, which often yielded different combinations of factors 37, 41-43. 
Furthermore many studies do not adequately account for the relationship 
between interventions such as tracheostomy, or  total parenteral nutrition and 
length of stay (i.e. duration of risk exposure), in that the longer a patient remains 
in ICU the more likely they are to receive one of these interventions 40,42, with the 
added confounder that those acquiring nosocomial infection tend to stay in ICU 
longer 41. Many epidemiological studies of infection in ICU include all-comers, 
whereas in this study we deliberately recruited a group who were thought to be 
at high risk.  All our patients had some form of invasive device in place, be it an 
endotracheal tube, central venous catheter or haemofiltration line, to facilitate 
the organ support that was an entry criterion.  With a median APACHE II of 22 
(IQR 18-28), these patients were a sicker subset of all ITU patients admitted to 
our unit.   The apparent ‘protective’ effect of blood transfusion was an 
unexpected finding, as previous studies have suggested it as a risk factor for 
infection42. This could be a genuine effect resulting from hetrologous blood’s 
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immunostimulatory effects44, or it may relate to failure to correct for 
unmeasured confounders. 
 
 
 
Conclusions 
This study has added new knowledge regarding the timing and magnitude of 
immune dysfuncti n occurring in critically ill adults, and related these findings 
to an important clinical outcome, namely the development of nosocomial 
infection.  We have shown that these effects are not restricted to patients with 
sepsis but occur in those with sterile insults as well.  We have also demonstrated 
the utility of blood cell-based markers of immune dysfunction and thus set the 
scene for future validation and intervention trials. 
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Figure legends 
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Figure 1. Measures of immune dysfunction by subsequent infection status 
Panel A: T-regs as a percentage of all CD4+ TH cells. p=0.012 for difference 
between outcomes, p=0.025 for difference over time by two way  ANOVA. 
Panel B: Monocyte HLA-DR expression. p=0.018 for difference between 
outcomes, p=0.56 for difference over time by two way  ANOVA. 
Panel C: Neutrophil CD88 expression p=0.0034 for difference between outcomes, 
p=0.001 for difference over time by two way  ANOVA. 
Data shown as mean and 95% confidence intervals. Analyses performed on log-
transformed data. 
PE, phycoerythrin; geoMCF, geometric mean cell fluorescence.
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Figure 2. Changes in measures of immune dysfunction before and after ICU-
acquired infection (n=33). 
 Panel A: Tregs as a percentage of all CD4+ve lymphocytes, p=0.28 by ANOVA. 
Panel B: Monocyte HLA-DR expression, p=0.56 by ANOVA. 
Panel C: Neutrophil CD88 expression,  p=0.95 by ANOVA. 
 All data shown as mean and 95% CI, all analyses performed on log-transformed 
data. Hatched line indicates the ‘cut-off’ for immune dysfunction. 
PE, phycoerythrin; geoMCF, geometric mean cell fluorescence. 
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Confirmed infections  
 Pneumonia-10  
(7 VAP) 
Blood stream infections-4 
Catheter-related blood stream 
infections-3 
Urinary tract infections-5 
Surgical site/soft tissue infections-4 
Probable infections  
 Pneumonia-4 (all VAP) 
Intra-abdominal infection-3 
 
Table 1. Site of infections acquired in ICU. 
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Infection category Organism Frequency 
Confirmed Staphylococcus aureus 3 
 Coagulase negative 
Staphylococci 
1 
Streptococcus 
pneumoniae 
1 
Other Streptococci 1 
Enterococcus faecalis 2 
Burkholderia cepacia 1 
Citrobacter braakii 1 
Coliform –no further 
specification 
1 
Enterobacter cloacae 3 
Escherichia coli 5 
Klebsiella pneumoniae 2 
Haemophilus influenzae 1 
Pseudomonas aeruginosa 3 
Anaerobes 1 
Candida albicans 4 
Herpes simplex 1 
Probable Staphylococcus aureus 1 
 Culture negative  4 
No samples taken as care 
withdrawn 
2 
Unlikely Staphylococcus aureus 2 
 Coagulase negative 
Staphylococci 
2 
Streptococcus 
pneumoniae 
1 
Acinetobacter baumannii 1 
Haemophilus influenzae 1 
Klebsiella pneumoniae 1 
Candida albicans 1 
Culture negative 2 
 
Table 2. Culture results from patients with confirmed, suspected and 
unlikely infections.   
More than one organism was isolated from some patients.  
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 Variable Infection No 
infection 
P value for 
Cox 
hazards 
analysis 
Pre-morbid factors Number of co-
morbid conditions 
by Charlson index, 
median (IQR)  
3 (1.5-4) 3 (1-5) 0.08 
% with chronic 
lung disease 
19% 9% 0.62 
% with diabetes 
mellitus 
18% 19% 0.36 
Age, median 
(range) 
60 (20-
88) 
59 (16-
85) 
0.34 
% male 61% 63% 0.06 
Admission factors Admission SOFA 
score, median 
(IQR) 
9 (6.5-
11) 
8 (4-10) 0.11 
Admission APACHE 
II Score, median 
(IQR) 
21 (18-
26) 
23.5(18.5-
29) 
0.26 
% fulfilling criteria 
for shock on 
admission 
76% 56% 0.28 
% admitted 
following surgery 
30% 23% 0.33 
% admitted 
following trauma 
1% 5% 0.79 
Illness 
course/interventions 
prior to endpoint 
achievement 
Peak SOFA score, 
median (IQR) 
9 (8-
12.5) 
8 (5-11) 0.29 
% intubated 94% 88% 0.22 
% with central 
venous catheter 
90% 88% 0.19 
% receiving renal 
replacement 
therapy 
42% 33% 0.23 
% with 
tracheostomy 
8% 6% 0.30 
% with urinary 
catheter 
92% 97% 0.30 
% receiving H2 100% 98% 0.70 
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antagonist/proton 
pump inhibitor 
% receiving 
corticosteroids 
30% 23% 0.74 
% receiving a blood 
transfusion 
52% 44% 0.002* 
% receiving total 
parenteral 
nutrition 
27% 18% 0.92 
Immune profiling % with elevated 
Tregs 
60% 29% 0.026* 
% with low CD88 94% 62% 0.009* 
% with low HLA-
DR 
85% 55% 0.29 
 
Table 3. Demographic and clinical factors amongst those with and without 
nosocomial infection.  
Right hand column indicates p value for hazard ratios determined during 
stepwise conditional evaluation, variables marked * entered the final model (see 
table 4 below).  
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Variable P value Hazard Ratio (95% CI) 
Overall model  0.001 NA 
*Elevated Tregs 0.026 2.4 (1.1-5.4) 
Neutrophil dysfunction 0.009 6.9 (1.6-30) 
Blood transfusion 0.002 0.3 (0.1-0.6) 
 
Table 4. Cox model for occurrence of nosocomial infection.   
*Elevated Treg cells were expressed as a time-dependent co-variate. 
NA = not applicable. 
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Number of 
dysfunctions a 
N= % acquiring 
nosocomial 
infection (95% CI) 
0 11 0  (0-0%) 
1 21 10% (0-22%) 
2 43 37% (23-52%) 
3 20 75% (56-94%) 
 
Table 5. Relationship between burden of immuno-dysfunction and 
acquisition of nosocomial infection.  
(ai.e. neutrophil dysfunction (as indicated by low CD88), monocyte deactivation 
(as indicated by low HLA-DR) and elevated regulatory T-cells). P=0.0004 by Chi 
squared test for trend. 
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Figure 1. Measures of immune dysfunction by subsequent infection status  
Panel A: T-regs as a percentage of all CD4+ TH cells. p=0.012 for difference between outcomes, p=0.025 
for difference over time by two way  ANOVA.  
Panel B: Monocyte HLA-DR expression. p=0.018 for difference between outcomes, p=0.56 for difference 
over time by two way  ANOVA.  
Panel C: Neutrophil CD88 expression p=0.0034 for difference between outcomes, p=0.001 for difference 
over time by two way  ANOVA.  
Data shown as mean and 95% confidence intervals. Analyses performed on log-transformed data.  
PE, phycoerythrin; geoMCF, geometric mean cell fluorescence.  
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Figure 2. Changes in measures of immune dysfunction before and after ICU-acquired infection (n=33).  
Panel A: Tregs as a percentage of all CD4+ve lymphocytes, p=0.28 by ANOVA.  
Panel B: Monocyte HLA-DR expression, p=0.56 by ANOVA.  
Panel C: Neutrophil CD88 expression,  p=0.95 by ANOVA.  
All data shown as mean and 95% CI, all analyses performed on log-transformed data. Hatched line indicates 
the ‘cut-off’ for immune dysfunction.  
PE, phycoerythrin; geoMCF, geometric mean cell fluorescence.  
 
149x225mm (600 x 600 DPI)  
 
 
Page 41 of 41 British Journal of Anaesthesia
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
